22nd Century Group logo
22nd Century Group XXII
€ 3.53 4.68%

Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025

report update icon

22nd Century Group DSO 2011-2026 | XXII

DSO Jährlich 22nd Century Group

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
75.3 35.7 73.6 28 12.2 12 21 1.22 2.19 31.8 2.48 788 8.37

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
788 1.22 84

DSO Vierteljährlich 22nd Century Group

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
74.3 87.8 46.1 - 32.5 24.1 24.1 - 88.3 101 75.5 - 22.6 18.5 9.1 - 19.4 22.7 28 27 26.9 30.6 19.6 10.9 12.2 13.6 12.6 11.1 12.7 11.5 13.6 14.7 19.3 22.4 20.4 1.12 1.21 1.32 1.39 1.59 1.75 2.03 3.79 - - - - - - - - - - - - - 20.4 44.2 -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
101 1.12 25.2

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
AbCellera Biologics AbCellera Biologics
ABCL
173 $ 3.44 -4.32 % $ 1.03 B canadaCanada
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
ADMA Biologics ADMA Biologics
ADMA
74.6 $ 15.36 -2.17 % $ 3.66 B usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
94.5 $ 3.53 -3.54 % $ 116 M franceFrance
AgeX Therapeutics AgeX Therapeutics
AGE
78.4 - -10.17 % $ 12.2 K usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
115 $ 20.28 0.65 % $ 2.56 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
12.5 - -19.68 % $ 18.4 M canadaCanada
Aptorum Group Limited Aptorum Group Limited
APM
20.6 $ 0.79 -1.15 % $ 4.31 M chinaChina
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
318 $ 2.01 -1.36 % $ 2.86 M chinaChina
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
33.4 $ 0.67 7.08 % $ 624 K israelIsrael
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
77.3 $ 14.05 -1.44 % $ 206 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
114 $ 74.36 -1.64 % $ 1.44 B usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Athersys Athersys
ATHX
22.6 - 3.77 % $ 22.4 M usaUSA
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
47.5 - - $ 521 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
105 $ 162.43 0.6 % $ 8.08 B usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
55.1 $ 8.49 -0.18 % $ 1.75 B usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
52.4 $ 65.66 -0.78 % $ 12.6 B usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
6.09 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
103 - -7.31 % $ 87 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
88.9 $ 61.3 1.21 % $ 11.8 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
182 - - $ 3.45 B usaUSA